Femasys Inc (FEMY): Depreciation & Amortization
$342.0K
Year ended 2025-12-31
$336.0K
Trailing 12 months to 2026-06-30
-15.2%
3-year compound annual growth
-12.8%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $342.0K | +15.0% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $297.3K | -38.5% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $483.5K | -13.9% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $561.2K | -5.0% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $591.1K | -13.0% | 2023-07-24, From 2021-01-01 |
| 2020-12-31 | $679.7K | n/a | 2022-03-24, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Femasys Inc (FEMY) | 2025-12-31 | $342.0K | +15.0% |
| QHSLab, Inc. (USAQ) | 2025-12-31 | $90.7K | -38.1% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $59.5K | 0.0% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $403.0K | -31.3% |
| Tenon Medical, Inc. (TNON) | 2025-12-31 | $262.0K | -35.8% |
| Intelligent Bio Solutions Inc. (INBS) | 2026-06-30 | $1.16M | -3.6% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $511.5K | +192.9% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $2.00M | n/a |
| Lucid Diagnostics Inc. (LUCD) | 2025-12-31 | $872.0K | -25.3% |
Compare FEMY, USAQ, VYCO, NONE. side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗